| FDA | Food and Drugs Admnistration |
| PEA | Palmitoylethanolamine |
| WHO | World Health Organization |
| WAT | White Adipose Tissue |
| BAT | Brown Adipose Tissue |
| BMI | Body Mass Index |
| TNF-α | Tunor necrosis factor-α |
| IL-6 | Interleukine 6 |
| IL-8 | Interleukine 8 |
| AGEs | Advanced Glycated End-products |
| ROS | Reactive Oxygen Species |
| BCS | Body Condition Score |
| CNS | Cresty Neck Scores |
| AOM | Anti-Obesity Medications |
| LEPR | Leptin Receptor |
| CRP | C-Reactive Protein |
| NLRP3 | Nod-Like Receptor Protein 3 inflammasome |
| MASLD | Metabolic Dysfunction-Associated Steatotic Liver Disease |
| NAEs | N-acylethanolamine |
| ECs | Endo-Cannabinoids |
| PPAR-α | Peroxisome Proliferator-Activated Receptor-α |